Overview


According to FutureWise analysis the market for antibiotics is expected to register a CAGR of 4.7% from 2023-2031.

Antibiotics are a class of drugs that fight against bacterial infections in humans and animals by killing or making it difficult for the bacteria to grow and reproduce. Antibiotics are produced on a large scale by fermentation induced by microorganisms in a large tank. A large tank includes the growth medium that provides nutrients for the microorganism’s growth. Optimization of temperature, oxygen, pH levels, and nutrient parameters in the fermentation tank is crucial to produce antibiotics. There are various types of antibiotics, including antibacterials, antifungals, antivirals, and antiparasitics. Among these, some drugs exhibit efficacy against a wide range of organisms, called "broad-spectrum antibiotics. Others are effective against only a few organisms and are called narrowspectrum antibiotics. The most commonly used antibiotics are antibacterials. Although antibiotics are useful in various infections, it's vital to understand that their effectiveness is limited to bacterial infections.

With the discovery of penicillin and the start of the antibiotic era, the body's natural defenses gained a powerful ally. In the 1920s, the British scientist Alexander Fleming was conducting experiments in his laboratory at St. Mary's Hospital in London when he stumbled upon a naturally occurring substance that could attack specific bacteria. In an experiment conducted in 1928, Fleming observed that colonies of the common Staphylococcus aureus bacteria on the same plate or petri dish were either weakened or killed by mold growth. He determined that the mold produced a substance capable of dissolving the bacteria. He named this substance penicillin in reference to the Penicillium mold responsible for its production.

FutureWise Market Research has published a report that provides an insightful analysis antibiotics Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. According to the analysis conducted by FutureWise research analysts, antibiotics Market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.

  • Novartis
  • Roche
  • Merck
  • GSK
  • Johnson and Johnson
  • Sanofi
  • AstraZeneca
  • Eli Lilly
  • AbbVie
  • Pfizer

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent developments by key players in Antibiotic Market:

In October 2021-The cephalosporin antibiotics division of GSK was purchased by Sandoz, a Novartis subsidiary. In more than 100 markets, it currently has the rights to three well-known brands (Zinnat, Zinacef, and Fortum), solidifying its position as the top antibiotics manufacturer in the world.

Due to the rise in infectious disease cases, there is a noticeable rise in the demand for antibiotics. Another factor driving the market's expansion is the high prevalence of infectious disorders like lower respiratory infections, pneumonia, malaria, and tuberculosis. Government and non-government organizations are being forced to invest in R&D programs and advance the creation of novel antibiotics and helpful regulatory rules in order to speed up the approval procedure and research financing. For instance, BARDA has supported numerous businesses in conjunction with the government to help develop novel treatments for infectious diseases. The top market companies' quick research and development efforts to introduce cutting-edge pharmaceuticals and attract potential customers have proven to be a key driver of the antibiotics market expansion. As a result of increasing medication resistance among people due to their modern lifestyle, the need for better antibiotics has developed over time. Additionally, these upgraded medications have a quicker and more efficient effect on those younger, such as youngsters and infants. These antibiotics have been improved in terms of safety and kid-friendliness. In the near future, many antibiotic medications are anticipated to be developed due to the collaborations for antibiotic development. To ease the financial burden of the medication development process, pharmaceutical companies are working together to create novel cures. However, Due to strict regulatory requirements for the adoption of new medications, the market for antibiotics is currently restricted. The negative effects of antibiotic treatments and the general lack of knowledge about these drugs are additional barriers to the market for antibiotics. Individuals are reporting negative effects from the new antibiotic medications that have been released onto the market. Antibiotics' ability to gain market share is further hampered by the abuse of these medications among younger consumers.

By Class

  • Beta Lactam And Beta Lactamase Inhibitors
    • Penicillin
    • Cephalosporin
    • Carbapenem
    • Monobactam
  • Quinolone
  • Macrolide
  • Others

By Drug Origin

  • Natural
  • Semisynthetic
  • Synthetic

By Spectrum of Activity

  • Broad-spectrum Antibiotic
  • Narrow-spectrum Antibiotic

By Route of Administration

  • Oral
  • Intravenous
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America & Europe together hold the biggest market share of 49% in 2022. These markets have a strong regulatory framework and an advanced healthcare infrastructure. The main drivers propelling the North American market are the increasing prevalence of infectious diseases and the rising government spending on healthcare. The American government is adopting several actions, including promoting R&D for novel infectious disease medicines and undertaking campaigns to promote antibiotic stewardship. Moreover, the primary factors influencing the demand for these medications in the European market are the quick growth of the healthcare infrastructure in several European nations, the rising investment in research and development activities, and the expanding number of hospitals in the region.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Antibiotics Market By Class, By Drug Origin, By Spectrum Of Activity, By Route Of Administration and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization services offered are free of charge with purchase of any license of the report.
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1 . Years Considered for the Study
         3.2 . Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1 . Secondary Data
          1.1.1 . Key Data from Secondary Sources
         1.2 . Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Antibiotics Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Antibiotics Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework

  • 6.   Antibiotics Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals and Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies

  • 7.  Antibiotics Market, By Class Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Beta Lactam & Beta Lactamase Inhibitors
           1.1. Penicillin
           1.2. Cephalosporin
           1.3. Carbapenem
           1.4. Monobactam 
         2. Quinolone
         3. Macrolide
         4. Others

  • 8.  Antibiotics Market, By Drug Origin Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Natural
        2. Semisynthetic
        3. Synthetic

  • 9.  Antibiotics Market, By Spectrum of Activity Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Broad-spectrum Antibiotic
        2. Narrow-spectrum Antibiotic

  • 10.  Antibiotics Market, By Route of Administration Analysis and Forecast 2023-2031 (USD Million)
    •   1. Oral
        2. Intravenous
        3 Others

  • 11.   North America Antibiotics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 12.   Latin America Antibiotics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 13.   Europe Antibiotics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        .2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 14.   Asia Pacific Antibiotics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 15.   Middle East and Africa Antibiotics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 16.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix

  • 17.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Novartis
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Roche
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Merck
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. GSK
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         14.5. Strategic Overview
        5. Johnson and Johnson
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Sanofi
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. AstraZeneca
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Eli Lilly  
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. AbbVie
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Pfizer
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview

  • 18.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by
                  administrations
        5. The overall economic slowdown of the developing and developed nations

  • 19.   FutureWise SME Key Takeaway Points for Client

Related Market

Carbapenem-based Antibiotics Market

Read More

Veterinary Antibiotics Market

Read More

Peptide Antibiotics Market

Read More
Partner

Our Clients